- Abstract
- METHOD
- Subjects
- Food and Substance Consumption in Pregnancy
- Perception of Medication Use and Adherence in Pregnancy
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
목차 (Table of Contents)
참고문헌 (Reference)
1 Jagielska I, "woman, pregnancy and a newborn child" 69 (69): 1108-1110, 2012
2 Dupraz J, "Tobacco and alcohol during pregnancy: prevalence and determinants in Geneva in 2008" 25 : 143-150, 2013
3 Mozurkewich E, "The mothers, Omega-3 and mental health study" 11 : 46-, 2011
4 Buscicchio G, "The effects of maternal caffeine and chocolate intake on fetal heart rate" 25 (25): 528-530, 2011
5 Hanieh S, "The effect of intermittent antenatal iron supplementation on maternal and infant outcomes in rural viet nam: a cluster randomised trial" 10 (10): 2013
6 "Statistics Korea"
7 O'Brien KO, "Serum 1,25-dihydroxyvitamin D and calcium intake affect rates of bone calcium deposition during pregnancy and the early postpartum period" 96 (96): 64-72, 2012
8 Oliveira FA, "Self-reported adherence to prescribed medicines during pregnancy" 34 (34): 147-152,
9 Lacroix I, "Prescription of drugs during pregnancy in France" 356 : 1735-1736, 2000
10 Andrade SE, "Prescription drug use in pregnancy" 191 (191): 398-407, 2004
1 Jagielska I, "woman, pregnancy and a newborn child" 69 (69): 1108-1110, 2012
2 Dupraz J, "Tobacco and alcohol during pregnancy: prevalence and determinants in Geneva in 2008" 25 : 143-150, 2013
3 Mozurkewich E, "The mothers, Omega-3 and mental health study" 11 : 46-, 2011
4 Buscicchio G, "The effects of maternal caffeine and chocolate intake on fetal heart rate" 25 (25): 528-530, 2011
5 Hanieh S, "The effect of intermittent antenatal iron supplementation on maternal and infant outcomes in rural viet nam: a cluster randomised trial" 10 (10): 2013
6 "Statistics Korea"
7 O'Brien KO, "Serum 1,25-dihydroxyvitamin D and calcium intake affect rates of bone calcium deposition during pregnancy and the early postpartum period" 96 (96): 64-72, 2012
8 Oliveira FA, "Self-reported adherence to prescribed medicines during pregnancy" 34 (34): 147-152,
9 Lacroix I, "Prescription of drugs during pregnancy in France" 356 : 1735-1736, 2000
10 Andrade SE, "Prescription drug use in pregnancy" 191 (191): 398-407, 2004
11 Jamie R Daw, "Prescription drug use during pregnancy in developed countries: a systematic review" 20 (20): 895-902, 2011
12 Olesen C, "Prescribing during pregnancy and lactation with reference to the Swedish classification system: a population-based study among Danish women" 78 (78): 686-692, 1999
13 Goh YI, "Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis" 28 (28): 680-, 2006
14 de Zeeuw P, "Prenatal exposure to cigarette smoke or alcohol and cerebellum volume in attention-deficit/hyperactivity disorder and typical development" 2 : 84-92, 2012
15 Sawicki E, "Medication use for chronic health conditions by subject attending an Australian maternity hospital" 51 (51): 333-338, 2011
16 Sadler TW, "Langman’s medical embryology" Williams and Wilkins 2006
17 Chan KK, "Iron supplement in pregnancy and development of gestational diabetes-a randomised placebo-controlled trial" 116 (116): 789-797, 2009
18 Rasmussen MM, "Folic acid supplementation in subject" 57 (57): A4134-, 2010
19 Nguyen P, "Effect of iron content on the tolerability of prenatal multivitamins in pregnancy" 15 (15): 17-24, 2008
20 Chelchowska M, "Effect of cigarette smoking on blood lead levels in subject" 16 (16): 196-204, 2012
21 Olesen C, "Drug use in first pregnancy and lactation: a population-based survey among Danish women: the EUROMAP group" 55 (55): 139-144, 1999
22 Koren G, "Compliance with prenatal vitamins. Subjects with morning sickness sometimes find it difficult" 52 (52): 1392-1393, 2006
23 M Saaka, "Combined Iron and Zinc Supplementation Improves Haematologic Status of Subject in Upper West Region of Ghana" 46 (46): 225-233, 2012
근거중심 의약품 정책 결정; 극복하기 어려운 과제인가? 한국 전문가의 생생한 의견
Rituximab 주입관련 부작용발생 및 위험인자 분석
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2027 | 평가예정 | 재인증평가 신청대상 (재인증) | |
2021-01-01 | 평가 | 등재학술지 유지 (재인증) | |
2018-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2015-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2011-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2009-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2006-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
2005-05-10 | 학술지등록 | 한글명 : 한국임상약학회지외국어명 : Korean Journal of Clinical Pharmacy | |
2005-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | |
2003-01-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.18 | 0.18 | 0.17 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.17 | 0.15 | 0.432 | 0.02 |